These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32882418)

  • 1. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
    Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors.
    Madadi NR; Penthala NR; Brents LK; Ford BM; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2019-21. PubMed ID: 23466226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.
    Franks LN; Ford BM; Madadi NR; Penthala NR; Crooks PA; Prather PL
    Eur J Pharmacol; 2014 Aug; 737():140-8. PubMed ID: 24858620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
    Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
    Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastering tricyclic ring systems for desirable functional cannabinoid activity.
    Petrov RR; Knight L; Chen SR; Wager-Miller J; McDaniel SW; Diaz F; Barth F; Pan HL; Mackie K; Cavasotto CN; Diaz P
    Eur J Med Chem; 2013 Nov; 69():881-907. PubMed ID: 24125850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tamoxifen derivative ridaifen-B is a high affinity selective CB
    Franks LN; Ford BM; Fujiwara T; Zhao H; Prather PL
    Toxicol Appl Pharmacol; 2018 Aug; 353():31-42. PubMed ID: 29906493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
    Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
    Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y
    Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
    Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
    ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
    Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
    Osman NA; Ligresti A; Klein CD; Allarà M; Rabbito A; Di Marzo V; Abouzid KA; Abadi AH
    Eur J Med Chem; 2016 Oct; 122():619-634. PubMed ID: 27448919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational investigation on the binding modes of Rimonabant analogs with CB1 and CB2.
    Liu C; Yuan C; Wu P; Zhu C; Fang H; Wang L; Fu W
    Chem Biol Drug Des; 2018 Sep; 92(3):1699-1707. PubMed ID: 29797785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
    Pinna G; Loriga G; Lazzari P; Ruiu S; Falzoi M; Frau S; Pau A; Murineddu G; Asproni B; Pinna GA
    Eur J Med Chem; 2014 Jul; 82():281-92. PubMed ID: 24922543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors.
    Reggio PH
    Curr Pharm Des; 2003; 9(20):1607-33. PubMed ID: 12871061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
    Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
    Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal Structure of the Human Cannabinoid Receptor CB2.
    Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
    Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.